#246 - AMA #45: Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent

This podcast episode explores the use of GLP-1 agonists and metformin in weight management and their potential geroprotective effects. The discussion highlights their mechanism of action, efficacy, and the current state of research. The speakers emphasize the popularity and promise of these drugs, particularly semaglutide and tirzepatide, and discuss their implications for diabetes management and longevity.